Sio Capital Management, LLC Otonomy, Inc. Put Options Transaction History

Sio Capital Management, LLC

  • $268 Million
  • Q2 2024

Put Options

2 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2017

Feb 14, 2018
SELL
$2.8 - $5.55 $282,520 - $559,995
-100,900 Closed
0 $0
Q3 2017

Nov 14, 2017
BUY
$3.2 - $20.8 $322,880 - $2.1 Million
100,900
100,900 $328,000

About OTONOMY, INC.

OTIC Quotes by TradingView
  • Ticker OTIC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,990,400
  • Description
  • Otonomy, Inc., a biopharmaceutical company, develops therapeutics for neurotology in the United States. The company offers OTO-313, a sustained-exposure formulation of N-methyl-D-aspartate receptor antagonist gacyclidine, which is in Phase II clinical trials to treat tinnitus; and OTO-413, a sustained-exposure formulation of brain-derived neurot...
More about OTIC
Track This Portfolio

Track Sio Capital Management, LLC Portfolio

Follow Sio Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sio Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sio Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email